Fresenius Medical Care AG FMCQF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 266.11M
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 8.97
- Price/Sales
- 0.55
- Dividend Yield (Trailing)
- 3.89%
- Dividend Yield (Forward)
- 3.89%
- Dividend Payment Schedule
- May
- Total Yield
- 9.41%
Company Profile
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Stock Style Box
- Mid Value
- Total Number of Employees
- 108,165
Competitors
Valuation
|
Metric
|
FMCQF
|
DVA
|
THC
|
|---|---|---|---|
Price/Earnings (Normalized) | 8.97 | 13.75 | 13.13 |
Price/Book Value | 0.83 | — | 4.39 |
Price/Sales | 0.55 | 0.88 | 0.98 |
Price/Cash Flow | 4.04 | 5.43 | 5.16 |
Price/Earnings
FMCQF
DVA
THC
Financial Strength
|
Metric
|
FMCQF
|
DVA
|
THC
|
|---|---|---|---|
Quick Ratio | 0.68 | 1.33 | 1.22 |
Current Ratio | 1.07 | 1.47 | 1.41 |
Interest Coverage | 4.76 | 3.47 | 5.71 |
Quick Ratio
FMCQF
DVA
THC
Profitability
|
Metric
|
FMCQF
|
DVA
|
THC
|
|---|---|---|---|
Return on Assets (Normalized) | 4.50% | 7.71% | 5.60% |
Return on Equity (Normalized) | 10.75% | — | 39.08% |
Return on Invested Capital (Normalized) | 6.66% | 12.79% | 10.73% |
Return on Assets
FMCQF
DVA
THC
Medical Care Facilities Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Genesis Healthcare Inc Class A
GENNQ
| LOCK|PFg | LOCK|^w | — | |||
| HCA Healthcare Inc
HCA
| LOCK|ptr%fx$ | LOCK|!>Dt | $92B | |||
| Fresenius SE & Co KGaA ADR
FSNUY
| — | LOCK|?&P#Q | $28B | |||
| Tenet Healthcare Corp
THC
| LOCK|S^knwcs | LOCK|MLP! | $20B | |||
| Fresenius Medical Care AG ADR
FMS
| LOCK|jdy>!cS | LOCK|&#Sm | $12B | |||
| Encompass Health Corp
EHC
| — | LOCK|%@$Z | $12B | |||
| DaVita Inc
DVA
| LOCK|$xy@n? | LOCK|%vrd$ | $11B | |||
| Universal Health Services Inc Class B
UHS
| LOCK|lr@gZRS | LOCK|vgKpM | $10B | |||
| Ensign Group Inc
ENSG
| — | LOCK|#T%^ | $10B |
United States